Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Cho

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 7, 2018
CD34<sup>+</sup> Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelodysplastic Syndrome Pere Barba, Rodrigo Martino, Qin Zhou, et al.
Blood Advances|January 3, 2024
A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemiaLeland L Metheny, Ronald Sobecks, Christina Cho, et al.
The Journal of Clinical Investigation|May 17, 2021
Regulation of intercellular biomolecule transfer-driven tumor angiogenesis and responses to anticancer therapiesZhen Lu, Angelica Ortiz, Ioannis I Verginadis, et al.
Transplantation and Cellular Therapy|November 30, 2025
Outcomes of Terminal Complement Blockade in Adults with High-Risk Transplant-Associated Thrombotic Microangiopathy: A Comparative AnalysisMohammad Alhomoud, Glenn Heller, Christina Cho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 28, 2017
Impact of Toxicity on Survival for Older Adult Patients after CD34<sup>+</sup> Selected Allogeneic Hematopoietic Stem Cell TransplantationGunjan L Shah, Michael Scordo, Satyajit Kosuri, et al.
Advances in Cell and Gene Therapy|November 7, 2022
Combining the Disease Risk Index and Hematopoietic Cell Transplant Co-Morbidity Index provides a comprehensive prognostic model for CD34<sup>+</sup>-selected allogeneic transplantationChristina Cho, Patrick Hilden, Scott T Avecilla, et al.
American Journal of Hematology|September 9, 2023
Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemiaKarthik Nath, Jasme Lee, Theresa A Elko, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 30, 2016
Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34<sup>+</sup> Selected Grafts for Allogeneic Hematopoietic Cell TransplantationPere Barba, Ravin Ratan, Christina Cho, et al.
British Journal of Haematology|August 24, 2023
The Simplified Comorbidity Index predicts non-relapse mortality in reduced-intensity conditioning allogeneic haematopoietic cell transplantationShlomo Elias, Samantha Brown, Sean M Devlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 23, 2017
The Impact of Toxicities on First-Year Outcomes after Ex Vivo CD34<sup>+</sup>-Selected Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic MalignanciesSatyajit Kosuri, Diego Adrianzen Herrera, Michael Scordo, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 7, 2018
CD34<sup>+</sup> Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelodysplastic Syndrome Pere Barba, Rodrigo Martino, Qin Zhou, et al.
Blood Advances|January 3, 2024
A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemiaLeland L Metheny, Ronald Sobecks, Christina Cho, et al.
The Journal of Clinical Investigation|May 17, 2021
Regulation of intercellular biomolecule transfer-driven tumor angiogenesis and responses to anticancer therapiesZhen Lu, Angelica Ortiz, Ioannis I Verginadis, et al.
Transplantation and Cellular Therapy|November 30, 2025
Outcomes of Terminal Complement Blockade in Adults with High-Risk Transplant-Associated Thrombotic Microangiopathy: A Comparative AnalysisMohammad Alhomoud, Glenn Heller, Christina Cho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 28, 2017
Impact of Toxicity on Survival for Older Adult Patients after CD34<sup>+</sup> Selected Allogeneic Hematopoietic Stem Cell TransplantationGunjan L Shah, Michael Scordo, Satyajit Kosuri, et al.
Advances in Cell and Gene Therapy|November 7, 2022
Combining the Disease Risk Index and Hematopoietic Cell Transplant Co-Morbidity Index provides a comprehensive prognostic model for CD34<sup>+</sup>-selected allogeneic transplantationChristina Cho, Patrick Hilden, Scott T Avecilla, et al.
American Journal of Hematology|September 9, 2023
Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemiaKarthik Nath, Jasme Lee, Theresa A Elko, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 30, 2016
Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34<sup>+</sup> Selected Grafts for Allogeneic Hematopoietic Cell TransplantationPere Barba, Ravin Ratan, Christina Cho, et al.
British Journal of Haematology|August 24, 2023
The Simplified Comorbidity Index predicts non-relapse mortality in reduced-intensity conditioning allogeneic haematopoietic cell transplantationShlomo Elias, Samantha Brown, Sean M Devlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 23, 2017
The Impact of Toxicities on First-Year Outcomes after Ex Vivo CD34<sup>+</sup>-Selected Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic MalignanciesSatyajit Kosuri, Diego Adrianzen Herrera, Michael Scordo, et al.
Pageof 10